•
Alibaba Health Information Technology Ltd (HKG: 0241), the health industry arm of Chinese e-commerce giant Alibaba Group, has announced strategic collaboration agreements with a consortium of pharmaceutical companies. The collaborations include US-based Viatris (NASDAQ: VTRS) and Chinese firms Qilu Pharmaceutical, Chongqing Taiji Industry (Group) Co., Ltd (SHA: 600129), Shandong Dyne…
•
Ant Group, the China-based fintech powerhouse, is reportedly pursuing the acquisition of Haodf.com, one of the country’s leading Internet healthcare platforms. This shift in negotiations comes after Alibaba Health Information Technology Ltd (HKG: 0241), Ant’s sister company, previously engaged in discussions with Haodf.com, according to local media sources. The two…